Chromosome patterns in rat hepatocytes during N-2-fluorenylacetamide carcinogenesis.
D000081:Acetamides / Q000008:administration & dosage / Q000009:adverse effects; D000284:Administration, Oral; D000818:Animals; D002273:Carcinogens / Q000008:administration & dosage; D006528:Carcinoma, Hepatocellular / Q000139:chemically induced* / Q000473:pathology; D002869:Chromosome Aberrations / Q000139:chemically induced*; D025063:Chromosome Disorders; D002875:Chromosomes; D003078:Colchicine / Q000008:administration & dosage; D004171:Diploidy; D005449:Fluorenes / Q000008:administration & dosage / Q000009:adverse effects*; D006498:Hepatectomy; D007274:Injections, Intraperitoneal; D007621:Karyotyping; D008099:Liver / Q000166:cytology; D008113:Liver Neoplasms; D008214:Lymphocytes / Q000166:cytology; D008297:Male; D008938:Mitosis / Q000187:drug effects; D009374:Neoplasms, Experimental / Q000139:chemically induced; D011230:Precancerous Conditions / Q000139:chemically induced*; D051381:Rats; D013737:Testis / Q000166:cytology; D013997:Time Factors
D000081:Acetamides; D002273:Carcinogens; D005449:Fluorenes; D003078:Colchicine